Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2023-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$170.7m reported value -24.0% vs Q4 2022
11positions
97.4%in top 10
0 new 3 added 5 reduced 1 sold out vs Q4 2022

Options: 0 call positions (— notional), 1 put positions ($70.6m notional) – listed below, not included above.

Holdings, Q1 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BLUEPRINT MEDICINES CORP COM BPMC BPMC 622,829 $28.0m16.42% 16.42% AddedShares held: Q3 2022 524.3k, Q4 2022 581.8k, Q1 2023 622.8k +41.1k +41,061 7.1%
2 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 1,018,474 $25.9m15.16% 15.16% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.1m, Q1 2023 1.0m -85.0k -85,041 -7.7%
3 MERUS N V COM MRUS MRUS 1,225,109 $22.5m13.21% 13.21% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.4m, Q1 2023 1.2m -207.0k -207,000 -14.4%
4 KYMERA THERAPEUTICS INC COM KYMR KYMR 601,325 $17.8m10.44% 10.44% ReducedShares held: Q3 2022 330.2k, Q4 2022 629.4k, Q1 2023 601.3k -28.1k -28,086 -4.5%
5 ARVINAS INC COM ARVN ARVN 628,941 $17.2m10.07% 10.07% ReducedShares held: Q3 2022 671.7k, Q4 2022 673.9k, Q1 2023 628.9k -45.0k -45,000 -6.7%
6 REGENXBIO INC COM RGNX RGNX 831,014 $15.7m9.21% 9.21% ReducedShares held: Q3 2022 967.7k, Q4 2022 897.7k, Q1 2023 831.0k -66.7k -66,670 -7.4%
7 UNIQURE NV SHS QURE QURE 637,526 $12.8m7.52% 7.52% AddedShares held: Q3 2022 841.5k, Q4 2022 624.9k, Q1 2023 637.5k +12.7k +12,672 2.0%
8 GENMAB A/S SPONSORED ADS GMAB GMAB 242,848 $9.2m5.37% 5.37% UnchangedShares held: Q3 2022 244.8k, Q4 2022 242.8k, Q1 2023 242.8k
9 ARGENX SE SPONSORED ADR ARGX ARGX 24,000 $8.9m5.24% 5.24% UnchangedShares held: Q3 2022 24.0k, Q4 2022 24.0k, Q1 2023 24.0k
10 SILENCE THERAPEUTICS PLC ADS SLN SLN 1,312,233 $8.1m4.77% 4.77% AddedShares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m +28.1k +28,100 2.2%
11 PIERIS PHARMACEUTICALS INC COM COM 4,552,876 $4.4m2.60% 2.60% UnchangedShares held: Q3 2022 4.0m, Q4 2022 4.6m, Q1 2023 4.6m

Sold out since Q4 2022

SecurityTickerShares held beforeValue then
AMRYT PHARMA PLC 2,098,993 $15.3m2.1m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 220,000 $70.6m220.0k shares New